These weapons are being prepared against killer coronas all over the world

New delhi date. 13 April 2020, Monday

The Corona virus has killed more than 1.14 million people worldwide and infected more than 18 million people. There is no solution to the epidemic yet, but preparations are under way. Many companies have submitted their plans to find the Corona vaccine, whose worldwide hopes for success.

Work on Plasma Therapy, 40 Vaccines in India

The Indian Medical Research Council is working towards whether the plasma of a patient recovering from coronas can be useful in treating other infected people. It is assumed that the antibodies that have been made in the body of a healthy person can work as a shield for others. Besides, work is underway to develop 40 vaccines but no vaccine has reached the next stage of testing.

In Spain, a drug has healed many patients

Spain's Cesidarma company claims successful treatment for 75 percent of patients with their vitamin supplement medications. At the same time, it is being tested on 300 patients in Madrid and Valencia. The company also advised ICMR to test this drug on 30-40 patients.

The Bangladeshi company will also start the test

Beacon Pharma, a pharmaceutical company in Bangladesh, has decided to test whether anti-viral drug Favipiravir in its clinic works for coronary patients. The company will try to test the safety of this drug compared to HCQ.

Six drugs Australia has identified are likely to be effective

Scientists in Australia claim to have identified six of the 10 thousand compounds and have also performed clinical trials to determine their efficacy.

Ready for Corona's US drug test

Pfizer, a US-based pharmaceutical giant, has paid $ 185 million to vaccinate biotech companies for mRNA vaccine and is expected to begin testing the vaccine on humans during the current April. The mRNA vaccine platform is more secure than the traditional vaccine and it is used more in treating infectious diseases as it is prepared on a lower budget. Apart from that, two other companies, namely CureWeek and Moderna, are also working towards producing such an mRNA vaccine.

Antiviral drug has had primary success

The Pfizer company claims that the anti-viral anti-viral virus has been successful in the clinic's primary test. At the same time, the JV company has the capacity to supply millions of vaccines by the end of the year. If the vaccine is approved, the companies claim they will produce several million doses of the vaccine by the end of 2021.